Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17- demethoxygeldanamycin [17-AAG]) in patients with solid tumors
M. W. Saif, C. Erlichman, T. Dragovich, D. Mendelson, D. Toft, F. Burrows, C. Storgard, D. Von Hoff
Dive into the research topics of 'Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17- demethoxygeldanamycin [17-AAG]) in patients with solid tumors'. Together they form a unique fingerprint.